-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AlCYrkqJL6f4v3ekm00asDzBVyXEjvv8WZ7+R9vPCc1mt5l6UcGkyEodGyu0L0Ye fdw9+MxVlsitE8RPhOaEOQ== 0000937889-05-000013.txt : 20050816 0000937889-05-000013.hdr.sgml : 20050816 20050816162211 ACCESSION NUMBER: 0000937889-05-000013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050815 FILED AS OF DATE: 20050816 DATE AS OF CHANGE: 20050816 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Coley Pharmaceutical Group, Inc. CENTRAL INDEX KEY: 0001319197 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061506689 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 93 WORCESTER ST. STREET 2: SUITE 101 CITY: WELLESLEY STATE: MA ZIP: 02481 BUSINESS PHONE: 617-348-1738 MAIL ADDRESS: STREET 1: C/O JAMES CHICOSKI; MINTZ, LEVIN, ET AL STREET 2: ONE FINANCIAL CENTER CITY: BOSTON STATE: MA ZIP: 02111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VENROCK ASSOCIATES CENTRAL INDEX KEY: 0000937889 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51472 FILM NUMBER: 051031023 BUSINESS ADDRESS: STREET 1: ROOM 5508 STREET 2: 30 ROCKEFELLER PLAZA CITY: NEW YORK STATE: NY ZIP: 10112 BUSINESS PHONE: 2126495600 MAIL ADDRESS: STREET 1: ROOM 5508 STREET 2: 30 ROCKEFELLER PLAZA CITY: NEW YORK STATE: NY ZIP: 10112 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2005-08-15 0001319197 Coley Pharmaceutical Group, Inc. COLY 0000937889 VENROCK ASSOCIATES 30 ROCKEFELLER PLAZA, ROOM 5508 NEW YORK NY 10112 0 0 1 0 Common Stock 2005-08-15 4 C 0 312945 A 312945 D Common Stock 2005-08-15 4 C 0 141022 A 453967 D Series F Convertible Preferred Stock 2005-08-15 4 C 0 1239889 D Common Stock 312945 0 D Series G Convertible Preferred Stock 2005-08-15 4 C 0 645881 D Common Stock 141022 0 D Upon the closing of the Issuer's initial public offering, each share of Series F Convertible Preferred Stock was automatically converted into 0.2523979 shares of the Issuer's Common Stock. Upon the closing of the Issuer's initial public offering, each share of Series G Convertible Preferred Stock was automatically converted into 0.2183406 shares of the Issuer's Common Stock. Shares of Preferred Stock were convertible into Common Stock at any time and had no expiration date. All outstanding shares of Preferred Stock were automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering. Not applicable. Anthony B. Evnin, General Partner 2005-08-16 -----END PRIVACY-ENHANCED MESSAGE-----